Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 5.8d

Adjusted Graft Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 11,993 98.0% 0.1% 11,993 96.5% 0.2% 38,083 82.9% 0.2% 64,901 60.9% 0.3%
Primary Diagnosis Glomerular Diseases 3,515 97.7% 0.3% 3,515 96.3% 0.3% 11,270 83.8% 0.4% 19,670 64.0% 0.6%
Diabetes 2,565 98.1% 0.3% 2,565 96.5% 0.4% 8,072 79.1% 0.6% 13,693 50.7% 0.8%
Hypertensive Nephrosclerosis 1,904 98.4% 0.3% 1,904 96.7% 0.4% 5,722 80.9% 0.7% 8,623 57.3% 1.0%
Polycystic Kidneys 1,348 98.5% 0.3% 1,348 97.8% 0.4% 4,017 90.9% 0.6% 6,342 74.6% 1.0%
Tubular and Interstitial Diseases 709 97.2% 0.6% 709 95.8% 0.7% 2,396 82.9% 1.0% 4,356 63.1% 1.1%
Renovascular & Other Vascular Diseases 249 98.9% 0.7% 249 96.9% 1.1% 986 82.1% 1.4% 2,088 55.3% 1.7%
Congenital, Rare Familial, & Metabolic Disorders 443 97.3% 0.8% 443 95.3% 1.1% 1,553 84.2% 1.2% 2,679 65.8% 1.6%
Neoplasms 38 + + 38 + + 149 76.4% 4.4% 266 64.3% 4.4%
Other 1,142 98.2% 0.4% 1,142 96.2% 0.6% 3,551 82.1% 0.8% 6,195 62.2% 1.0%
Unknown 80 100.0% 0.0% 80 98.8% 1.2% 367 79.4% 2.4% 989 58.1% 2.3%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.